Analysis of Axl expression and activation in pancreatic cancer patient samples has been correlated with a poor prognosis (21, 22) and Axl activation in cancer cells has been shown to support EMT, cell proliferation, metastasis and drug resistance (5). This evidence concerns the gene AXL and pancreatic neoplasm.